Moderna Seeks FDA Authorization of Omicron-Specific Booster

The pharmaceutical giant Moderna says its updated 'bivalent' booster shot provides a stronger immune response against the Omicron variant of COVID-19 specifically. This week, Moderna plans to submit preliminary data to U.S. health officials in the hopes that its new booster will be available later this summer. Dr. Sampson Davis, emergency medicine physician, joins Cheddar News to discuss.
More Videos
Women Hold the Key to our Climate Future
Zainab Salbi, founder of Women for Women International and co-founder of Daughters for Earth, shares why she is putting women in positions of power to fight the climate crisis.
Get an Early Look at the New York Auto Show
U.S. Nissan head Jérémie Papin joins from the New York International Auto Show to give a preview of what’s to come from the carmaker – including the 2025 Nissan Kicks.
Load More